# CORRESP — iBio, Inc. (IBIO) (CIK 0001420720) > iBio, Inc. (IBIO) (CIK 0001420720) → SEC staff · filed 2026-02-05 · ticker IBIO · SIC 2834 ## What is this A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters. ## Key facts - **Accession number:** 0001104659-26-011059 - **Form:** CORRESP - **Filer:** iBio, Inc. (IBIO) (CIK 0001420720) - **CIK:** 0001420720 - **Ticker:** IBIO - **Filed:** 2026-02-05 - **SIC industry:** 2834 - **HQ:** New York, NY ## Primary source PDF letter: https://www.sec.gov/Archives/edgar/data/1420720/000110465926011059/filename1.htm EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1420720&type=UPLOAD&dateb=&owner=include&count=40 ## Other comment-letter activity for iBio, Inc. (IBIO) (CIK 0001420720) - UPLOAD — 2026-03-04 — /comment-letter/0000000000-26-002235 - CORRESP — 2026-03-04 — /comment-letter/0001104659-26-023517 - UPLOAD — 2026-02-05 — /comment-letter/0000000000-26-001251 ## Citation > US Securities and Exchange Commission, EDGAR CORRESP comment letter, iBio, Inc. (IBIO) (CIK 0001420720) (CIK 0001420720), filed 2026-02-05, accession 0001104659-26-011059. Retrieved via MORVS 2026-11-14 from https://api.morvs.ai/comment-letter/0001104659-26-011059. --- *[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*